Redhill Biopharma
RDHL
#11160
Rank
A$3.77 M
Marketcap
A$0.42
Share price
-13.08%
Change (1 day)
-73.67%
Change (1 year)

Redhill Biopharma (RDHL) - Total assets

Total assets on the balance sheet as of June 2026 : A$39.69 Million

According to Redhill Biopharma's latest financial reports the company's total assets are A$39.69 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Redhill Biopharma - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$37.83 M30.45%
2024-12-31A$29 M-14.25%
2023-12-31A$33.82 M-85.51%
2022-12-31A$0.23 B-6.59%
2021-12-31A$0.24 B6.62%
2020-12-31A$0.23 B121.48%
2019-12-31A$0.10 B19.46%
2018-12-31A$88.59 M20.61%
2017-12-31A$73.45 M-28.66%
2016-12-31A$0.10 B12.23%
2015-12-31A$91.73 M160.17%
2014-12-31A$35.25 M119.32%
2013-12-31A$16.07 M-16.87%
2012-12-31A$19.33 M-1.77%
2011-12-31A$19.68 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
A$222.54 B 560,530.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$196.10 B 493,932.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$143.68 B 361,870.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$60.21 B 151,597.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
A$3.26 B 8,133.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel